We are live on ! Find out more
BIMI

BIMI International Medical Inc. Common Stock

Delisted

BIMI was delisted on the 21st of August, 2024.

6 hedge funds and large institutions have $649K invested in BIMI International Medical Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more capital invested

Capital invested by funds: $169K → $649K (+$480K)

14% less funds holding

Funds holding: 76 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

BIMI Hedge Fund Activity: Q2 2018 in Review

6 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q2 2018, worth a combined $649K — up 285% from $169K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BIMI and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.

The largest buyer was Deutsche Bank, adding an estimated $126K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $51K sold.

  • 6 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q2 2018, down from 7 in Q1 2018.
  • Funds reported $649K of BIMI International Medical Inc. Common Stock stock for Q2 2018, up 285% quarter-over-quarter.
  • 2 funds opened new BIMI International Medical Inc. Common Stock positions in Q2 2018 and 3 closed out, a net change of -1 holder.
  • The largest BIMI International Medical Inc. Common Stock buyer in Q2 2018 was Deutsche Bank, an estimated $126K added.
  • The largest BIMI International Medical Inc. Common Stock seller in Q2 2018 was Susquehanna International Group, an estimated $51K sold.

Based on aggregated 13F filings for Q2 2018.